Home > Medical Diagnostic Equipment >

C. R. Bard Fluency Plus Vascular Stent for Dissection Restenosis after PTA in Peripheral Arteries

Product Categories

Sichuan Hundred Medcal Technology Co., Ltd.

Trust Seal

Verified Supplier

Credit Check

Supplier Assessment

Contact Now

C. R. Bard Fluency Plus Vascular Stent for Dissection Restenosis after PTA in Peripheral Arteries

Name: C R Bard Fluency Plus Vascular Stent for Dissection Restenosis after PTA in Peripheral Arteries
Brand: C. R. Bard
Price: 1 USD

Quality C. R. Bard Fluency Plus Vascular Stent for Dissection Restenosis after PTA in Peripheral Arteries for sale

Brand Name : C. R. Bard

Model Number : FVM10100

Certification : ce

Place of Origin : CHINA

MOQ : 1000pcs

Price : Negotiable

Payment Terms : L/C,T/T,Westen Union,Money Gram,Paypal/VTB

Supply Ability : 100000pc/month

Delivery Time : 10-15days

Packaging Details : Carton

Product name : C. R. Bard Fluency Plus Vascular Stent

Diameter : 12mm

Outer diameter : 13.5mm

Length : 20/30/40/60/80MM

Conveyor rod : 80/117cm

Feature : Disposable

Contact Now

Description

The C. R. Bard Fluency Plus Vascular Stent (Model: FVM10100) is a self-expanding endovascular prosthesis designed for the treatment of stenotic or occlusive lesions in the iliac and femoral arteries. C. R. Bard Fluency Plus Vascular Stent consists of a nitinol stent framework encapsulated between an inner and outer layer of expanded polytetrafluoroethylene (ePTFE), creating a durable, blood-tight lumen. C. R. Bard Fluency Plus Vascular Stent is pre-mounted on a low-profile delivery system for precise deployment during minimally invasive procedures.

Primary Function

This covered stent is used to restore and maintain vessel patency in peripheral arteries. Its key functions include:

Scaffolding: Providing mechanical support to counteract elastic recoil and compression in atherosclerotic arteries.
Barrier Function: The ePTFE covering acts as a physical barrier to prevent tissue prolapse and plaque intrusion into the vessel lumen.
Sealing: Managing dissections or post-balloon angioplasty flaps by apposing the vessel wall and creating a smooth flow surface.

Key Features and Advantages

Advanced Stent Design: The self-expanding nitinol stent offers chronic outward force for sustained vessel support, with four radiopaque tantalum markers at each end for precise fluoroscopic visualization during placement.
Proven Graft Material: The ePTFE covering is designed for rapid endothelialization and resistance to thrombosis. The carbon-coated inner surface is intended to enhance hemocompatibility.
Precise Delivery: The integrated delivery system (80/117 cm lengths) allows controlled, accurate deployment, facilitating placement in tortuous anatomy.
Comprehensive Size Range: Available in diameters of 12 mm and 13.5 mm, and lengths from 20 mm to 80 mm, providing options for various lesion characteristics.
Clinical Versatility: It addresses multiple complex scenarios, including flow-limiting dissections, restenosis, and vessel obstruction following angioplasty or atherectomy.

Indications for Use

The stent is indicated for use in the iliac and femoral arteries for:

The treatment of residual stenosis after balloon angioplasty (particularly in Fontaine Stage III/IV patients).
Management of arterial dissections.
Addressing plaque disruption or lumen compromise post-angioplasty.
Treatment of stenosis or re-occlusion, including after thrombolysis or thrombectomy.
Treatment of in-stent restenosis or re-occlusion.

Application Scenarios

Peripheral Artery Disease (PAD): Revascularization of iliac and femoral arteries in patients with claudication or critical limb ischemia.
Post-Angioplasty Complications: As a bail-out device for suboptimal results from plain balloon angioplasty, such as significant dissections or elastic recoil.
Complex Lesions: Used in calcified, tortuous, or recurrent lesions where a covered stent may offer superior patency compared to bare-metal stents.

Clinical Value

The Bard Fluency Plus Stent provides a critical solution for maintaining long-term vessel patency in challenging peripheral lesions. Its covered design is particularly beneficial in preventing restenosis caused by neointimal hyperplasia and in managing complications that bare-metal stents cannot effectively address. By offering a combination of flexibility, radial strength, and a biocompatible barrier, it supports positive patient outcomes in complex endovascular interventions.

Product Tags: